| Urine biopsy—liquid gold for molecular detection and surveillance of bladder cancer U Satyal, A Srivastava, PH Abbosh Frontiers in oncology 9, 1266, 2019 | 46 | 2019 |
| Neutralization of chemokine CXCL14 (BRAK) expression reduces CCl4 induced liver injury and steatosis in mice J Li, J Gao, D Yan, Y Yuan, S Sah, U Satyal, M Liu, W Han, Y Yu European journal of pharmacology 671 (1-3), 120-127, 2011 | 30 | 2011 |
| Clinical implications of molecular subtyping in bladder cancer U Satyal, RK Sikder, D McConkey, ER Plimack, PH Abbosh Current opinion in urology 29 (4), 350-356, 2019 | 22 | 2019 |
| Synthesis, characterization, and biological activity of a triphenylphosphonium-containing imidazolium salt against select bladder cancer cell lines ML Stromyer, MR Southerland, U Satyal, RK Sikder, DJ Weader, ... European journal of medicinal chemistry 185, 111832, 2020 | 21 | 2020 |
| Interfacially engineered pyridinium pseudogemini surfactants as versatile and efficient supramolecular delivery systems for DNA, siRNA, and mRNA U Satyal, B Draghici, LL Dragic, Q Zhang, KW Norris, M Madesh, ... ACS applied materials & interfaces 9 (35), 29481-29495, 2017 | 15 | 2017 |
| Synthetic delivery systems for DNA, siRNA, and mRNA based on pyridinium amphiphiles MA Ilies, U Satyal, VD Sharma Control of Amphiphile self-assembling at the molecular level: Supra …, 2017 | 7 | 2017 |
| Synthesis, characterization, and biological activity of anthraquinone-substituted imidazolium salts for the treatment of bladder cancer ML Stromyer, DJ Weader, U Satyal, PH Abbosh, WJ Youngs Bladder Cancer 6 (4), 471-479, 2020 | 4 | 2020 |
| Interface-Engineered Amphiphilic Block Copolymers with Tuned Enzymatic Resistance for Controlled Delivery of Chemotherapeutic Drugs U Satyal, VD Sharma, JA Shif, MA Ilies Control of Amphiphile Self-Assembling at the Molecular Level: Supra …, 2017 | 2 | 2017 |
| Expression and Purification of Bioactive High-Purity Recombinant Mouse CXCL14 in Escherichia coli J Li, J Gao, S Sah, U Satyal, R Zhang, W Han, Y Yu Applied biochemistry and biotechnology 164, 1366-1375, 2011 | 2 | 2011 |
| Urine biopsy as dynamic marker to enhance clinical staging of urothelial carcinoma U Satyal, D Liu, M Slifker, RK Alpaugh, CD Lallas, E Trabulsi, ... Cancer Research 81 (13_Supplement), 548-548, 2021 | 1 | 2021 |
| Cancer associated fibroblast dependency in a model of bladder cancer H Valentine, U Satyal, L Bukavina, H Uddin, Y Beyamin, R Arya, ... Cancer Research 84 (6_Supplement), 1436-1436, 2024 | | 2024 |
| Urine-based liquid biopsy test for the detection of residual bladder cancer in radical cystectomy patients R Arya, H Valentine, U Satyal, R Chelluri, M Li, P Abbosh Cancer Research 84 (6_Supplement), 3701-3701, 2024 | | 2024 |
| Cancer-associated fibroblasts potentiate subcutaneous tumor growth in a novel bladder cancer mouse model with a genotype dependency HL Valentine, U Satyal, A Metz, L Bukavina, PH Abbosh Cancer Research 83 (7_Supplement), 2884-2884, 2023 | | 2023 |
| Second generation imidazolium compounds as tumor-specific intravesical therapeutic agents for non-muscle invasive bladder cancer U Satyal, D Weader, H Valentine, M Stromyer, WJ Youngs, PH Abbosh Cancer Research 82 (12_Supplement), 4058-4058, 2022 | | 2022 |
| Development of customizable bladder cancer mouse model using CRISPR HL Valentine, U Satyal, PH Abbosh Cancer Research 82 (12_Supplement), 942-942, 2022 | | 2022 |
| Azolium salts for treatment of non-muscle invasive bladder cancer WJ Youngs, PH Abbosh, ML Stromyer, MR Southerland, U Satyal, ... US Patent 11,197,873, 2021 | | 2021 |
| Changes in mouse bladder cancer microbiome associated with exposure to bladder carcinogen N-butyl-N-(4-hydroxybutyl) nitrosamine R Ginwala, J Franklin, JR White, U Satyal, A Srivastava, PH Abbosh Cancer Research 81 (13_Supplement), 2912-2912, 2021 | | 2021 |
| Novel imidazolium compounds as intravesical therapeutic agents for non-muscle invasive bladder cancer U Satyal, A Srivastava, DJ Weader, ML Stromyer, MR Southerland, ... Cancer Research 80 (16_Supplement), 6366-6366, 2020 | | 2020 |
| Novel role of ketone body metabolism in acquired gemcitabine resistance. PH Abbosh, U Satyal, D Liu, I Ibragimova, L Szeto, B Miron, J Ford, ... CLINICAL CANCER RESEARCH 26 (15), 60-61, 2020 | | 2020 |
| Abstract B29: Use of deep sequencing of urinary DNA as a biomarker of residual disease status at the time of radical cystectomy PH Abbosh, U Satyal, D Liu, I Ibragimova, L Szeto, B Miron, J Ford, ... Clinical Cancer Research 26 (15_Supplement), B29-B29, 2020 | | 2020 |
MARC A ILIESProfessor, Temple University School of PharmacyVerified email at temple.edu
